Why Partner?
The Market Access for CNS Therapeutics Summit is the only event dedicated exclusively to CNS market access, offering unmatched focus and relevance. With the global CNS therapeutics market projected to exceed $80bn by 2025, this Summit connects you directly with senior decision-makers seeking expert partners in strategy, operations, and tech solutions. Unlike broader healthcare events, this summit zeroes in on the complex, evolving CNS space, where innovation is booming but access hurdles are steep. If you want to stand out to CNS market leaders and position your brand as essential to their success, this is your most targeted, strategic opportunity.
Experts need your help with:
- Software solutions and data analysis to support market access
- Market access specialists with strategy and/or operational expertise to support pre-launch to in-market access
Get in touch below to find out more:
Our Current Partner:
Why Partner with the Summit?
Gain Direct Access to a Focused Buyer Audience:
Unlike broader life sciences events, this summit exclusively targets CNS market access professionals - giving your team direct exposure to the decision-makers actively seeking expert vendors in strategy, operations, and data-driven solutions.
Brand Positioning at the Heart of CNS Innovation:
With the CNS space undergoing a commercial resurgence, this summit places your brand at the centre of discussions on market access challenges in neuroimmunology, neurodegeneration, and psychiatric care, where demand for external expertise is at an all-time high.
High-Value Networking with Minimal Competition:
As the only event of its kind, you won’t compete for attention among unrelated therapeutic areas. This is your opportunity to stand out, build high-quality leads, and form strategic partnerships with companies shaping the future of CNS therapeutics.
Who Will You Meet?
